SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. F. Deacon, H. E. Lebovitz, Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas, Diabetes, Obesity and Metabolism, 2016, 18, 4
  2. 2
    Beth D. Mitchell, Xuanyao He, Ian M. Sturdy, Andrew P. Cagle, Julie A. Settles, GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN, Endocrine Practice, 2016, 22, 2, 123

    CrossRef

  3. 3
    Edward A. S. Duncan, David Fitzpatrick, Improving self-referral for diabetes care following hypoglycaemic emergencies: a feasibility study with linked patient data analysis, BMC Emergency Medicine, 2016, 16, 1

    CrossRef

  4. 4
    Melanie Villani, Natalie Nanayakkara, Sanjeeva Ranasinha, Chin Yao Tan, Karen Smith, Amee Morgans, Georgia Soldatos, Helena Teede, Sophia Zoungas, Utilisation of emergency medical services for severe hypoglycaemia: an unrecognised health care burden, Journal of Diabetes and its Complications, 2016,

    CrossRef

  5. 5
    Elisabetta Salutini, Cristina Bianchi, Massimo Santini, Angela Dardano, Giuseppe Daniele, Giuseppe Penno, Roberto Miccoli, Stefano Del Prato, Access to emergency room for hypoglycaemia in people with diabetes, Diabetes/Metabolism Research and Reviews, 2015, 31, 7
  6. 6
    P. McEwan, B. Larsen Thorsted, M. Wolden, J. Jacobsen, M. Evans, Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England, BMJ Open Diabetes Research & Care, 2015, 3, 1, e000057

    CrossRef

  7. 7
    Nick Freemantle, Muhammad Mamdani, Tina Vilsbøll, Jens Harald Kongsø, Kajsa Kvist, Stephen C. Bain, IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy, Diabetes Therapy, 2015, 6, 4, 573

    CrossRef

  8. 8
    R. J. Barranco, F. Gomez-Peralta, C. Abreu, M. Delgado, R. Palomares, F. Romero, C. Morales, M. A. Cal, J. M. Garcia-Almeida, F. Pasquel, G. E. Umpierrez, Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project, Diabetic Medicine, 2015, 32, 11
  9. 9
    Marc Evans, Phil McEwan, Volker Foos, Insulin degludec early clinical experience: does the promise from the clinical trials translate into clinical practice—a case-based evaluation, Journal of Medical Economics, 2015, 18, 2, 96

    CrossRef

  10. 10
    R. Rajendran, D. Hodgkinson, G. Rayman, Patients with diabetes requiring emergency department care for hypoglycaemia: characteristics and long-term outcomes determined from multiple data sources, Postgraduate Medical Journal, 2015, 91, 1072, 65

    CrossRef

  11. 11
    J. Elliott, R. M. Jacques, J. Kruger, M. J. Campbell, S. A. Amiel, P. Mansell, J. Speight, A. Brennan, S. R. Heller, Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes, Diabetic Medicine, 2014, 31, 7
  12. 12
    G. Marchesini, G. Veronese, Gabriele Forlani, Giulia Forlani, L.M. Ricciardi, A. Fabbri, The management of severe hypoglycemia by the emergency system: The HYPOTHESIS study, Nutrition, Metabolism and Cardiovascular Diseases, 2014, 24, 11, 1181

    CrossRef

  13. 13
    Jason Gordon, Marc Evans, Phil McEwan, Steve Bain, Jiten Vora, Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom, Diabetes Therapy, 2013, 4, 1, 51

    CrossRef

  14. 14
    A.H. Barnett, R. Brice, W. Hanif, J. James, H. Langerman, Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents, Current Medical Research and Opinion, 2013, 29, 11, 1503

    CrossRef

  15. 15
    Kamlesh Khunti, Harriet Fisher, Sanjoy Paul, Mohammad Iqbal, Melanie J. Davies, A. Niroshan Siriwardena, Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: A retrospective study, Primary Care Diabetes, 2013, 7, 2, 159

    CrossRef

  16. 16
    N. Hex, C. Bartlett, D. Wright, M. Taylor, D. Varley, Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs, Diabetic Medicine, 2012, 29, 7
  17. 17
    Harold E. Lebovitz, Arne Melander, Sulfonylureas and meglitinides: insights into physiology and translational clinical utility,